SUPRAX
- Product NDC
- 70934-079
- 11-digit product format
- 709340079
- Labeler code
- 70934
- Product ID
- 70934-079_9abb3209-588b-fdba-e053-2a95a90ae15b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cefixime
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- NDA203195
- Marketing category
- NDA
- Marketing start
- 2018-02-09
- Marketing end
- 0000-00-00
- Substance
- CEFIXIME
- Active strength
- 400 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70934-079-01 | SUPRAX | 1 in 1 BOTTLE, PLASTIC | CAPSULE | 1 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70934-079 | SUPRAX (CEFIXIME) CAPSULE [DENTON PHARMA, INC. DBA NORTHWIND PHARMACEUTICALS] | 2 | Legacy NDC, 1 package rows | 20191228_655a59ba-08e9-51d4-e053-2991aa0aef34.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 70934-079-01 | 70934007901 | 1 in 1 BOTTLE, PLASTIC | Historical |